Trial Outcomes & Findings for Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers (NCT NCT02533726)

NCT ID: NCT02533726

Last Updated: 2018-04-09

Results Overview

NPUAP criteria include 4 stages and 2 unstaged criteria. The count of patients with pressure ulcer according to any of the criteria are reported. * Stage 1: Non-blanchable erythema of intact skin * Stage 2: Partial-thickness skin loss with exposed dermis * Stage 3: Full-thickness skin loss * Stage 4: Full-thickness skin and tissue loss * Unstageable: Obscured full-thickness skin and tissue loss * Suspected deep tissue injury: Persistent non-blanchable deep red, maroon or purple discoloration

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1312 participants

Primary outcome timeframe

Duration of ICU admission (average 1 week)

Results posted on

2018-04-09

Participant Flow

Participant milestones

Participant milestones
Measure
Treatment - Optimal Turning
All patients had a sensor applied. Patients within this arm received care from nurses who had access to a User Dashboard that provided visual advisories for patient turning, based on data obtained from the wearable patient sensor.
Control - Standard Care
All patients had a sensor applied. Patients within this arm received care from nurses who did not have access to a User Dashboard that provided visual advisories for patient turning. Instead, these patients received standard care practices, patient turning initiated by nurses as necessary.
Initial Allocation
STARTED
659
653
Initial Allocation
COMPLETED
659
653
Initial Allocation
NOT COMPLETED
0
0
Treatment
STARTED
709
603
Treatment
Per Protocol Population
671
555
Treatment
COMPLETED
709
603
Treatment
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Treatment - Optimal Turning
n=671 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who had access to a User Dashboard that provided visual advisories for patient turning, based on data obtained from the wearable patient sensor.
Control - Standard Care
n=555 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who did not have access to a User Dashboard that provided visual advisories for patient turning. Instead, these patients received standard care practices, patient turning initiated by nurses as necessary.
Total
n=1226 Participants
Total of all reporting groups
Age, Continuous
60 years
STANDARD_DEVIATION 17 • n=5 Participants
60 years
STANDARD_DEVIATION 18 • n=7 Participants
60 years
STANDARD_DEVIATION 17 • n=5 Participants
Sex: Female, Male
Female
298 Participants
n=5 Participants
253 Participants
n=7 Participants
551 Participants
n=5 Participants
Sex: Female, Male
Male
373 Participants
n=5 Participants
302 Participants
n=7 Participants
675 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
113 Participants
n=5 Participants
82 Participants
n=7 Participants
195 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
538 Participants
n=5 Participants
458 Participants
n=7 Participants
996 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
20 Participants
n=5 Participants
15 Participants
n=7 Participants
35 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Duration of ICU admission (average 1 week)

Population: Per protocol population according to treatment received (met minimum monitoring period (\>2h) and did not receive both interventions)

NPUAP criteria include 4 stages and 2 unstaged criteria. The count of patients with pressure ulcer according to any of the criteria are reported. * Stage 1: Non-blanchable erythema of intact skin * Stage 2: Partial-thickness skin loss with exposed dermis * Stage 3: Full-thickness skin loss * Stage 4: Full-thickness skin and tissue loss * Unstageable: Obscured full-thickness skin and tissue loss * Suspected deep tissue injury: Persistent non-blanchable deep red, maroon or purple discoloration

Outcome measures

Outcome measures
Measure
Treatment - Optimal Turning
n=671 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who had access to a User Dashboard that provided visual advisories for patient turning, based on data obtained from the wearable patient sensor.
Control - Standard Care
n=555 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who did not have access to a User Dashboard that provided visual advisories for patient turning. Instead, these patients received standard care practices, patient turning initiated by nurses as necessary.
Count of Participants With Pressure Ulcer According to the National Pressure Ulcer Advisory Panel (NPUAP) Criteria for Pressure Ulcers
5 Participants
15 Participants

SECONDARY outcome

Timeframe: Duration of ICU admission (average 1 week)

Population: Per protocol population according to treatment received (met minimum monitoring period (\>2h) and did not receive both interventions)

Compliance is reported as the percentage of time during ICU admission that patients received turning every two hours.

Outcome measures

Outcome measures
Measure
Treatment - Optimal Turning
n=671 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who had access to a User Dashboard that provided visual advisories for patient turning, based on data obtained from the wearable patient sensor.
Control - Standard Care
n=555 Participants
All patients had a sensor applied. Patients within this arm received care from nurses who did not have access to a User Dashboard that provided visual advisories for patient turning. Instead, these patients received standard care practices, patient turning initiated by nurses as necessary.
Compliance With Patient Turning Procedures
67 percentage of time
Standard Deviation 19.5
54 percentage of time
Standard Deviation 22.3

Adverse Events

Treatment - Optimal Turning

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control - Standard Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr David Pickham

Stanford University School of Medicine

Phone: 650 701 6830

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place